Search clinical trials for: PTI-801
Total 5418 results
-
Ankyra Therapeutics, IncRecruitingSolid Tumor | Non Small Cell Lung Cancer | Advanced Solid Tumor | Metastatic Solid Tumor | Malignant Solid Tumor | Cutaneous Tumor | Subcutaneous Tumor | Metastasis to Soft TissueUnited States, Canada
-
Zhejiang UniversityRecruitingTransthyroxin Amyloidosis CardiomyopathyChina
-
Auregen Biotherapeutics, SARecruitingMicrotiaUnited States
-
Auregen Biotherapeutics, SARecruiting
-
Betta Pharmaceuticals Co., Ltd.Recruiting
-
Innovo Therapeutics, Inc.Recruiting
-
AUG TherapeuticsRecruitingLeukocyte Adhesion DeficiencyUnited States
-
Heuron Inc.RecruitingBrain MetastasesKorea, Republic of
-
Kiora Pharmaceuticals, Inc.RecruitingRetinitis Pigmentosa | ChoroideremiaAustralia
-
Aardvark Therapeutics, Inc.Children's Hospital Colorado; Stanford UniversityRecruiting
-
Stoke Therapeutics, IncEnrolling by invitationDravet SyndromeUnited States
-
CorrectSequence Therapeutics Co., LtdFirst Affiliated Hospital of Guangxi Medical UniversityActive, not recruiting
-
Blue Blood Biotech Corp.Completed
-
Paean Biotechnology Inc.CompletedDermatomyositis | PolymyositisKorea, Republic of
-
MedRhythms, Inc.Active, not recruitingChronic StrokeUnited States
-
Auregen Biotherapeutics, SAEnrolling by invitation
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
Fervent PharmaceuticalsICON plcCompletedVasomotor Symptoms | MenopauseUnited States
-
Stemline Therapeutics, Inc.CompletedStudy of the PI3K Inhibitor SL-901 in Patients With Advanced Solid Tumors With Advanced Solid TumorsAdvanced Solid TumorUnited Kingdom
-
Asklepios Biopharmaceutical, Inc.Active, not recruiting
-
Ancora Bio, Inc. d/b/a EmbarkNeuro, Inc.Active, not recruitingMajor Depressive DisorderUnited States
-
Dr. Anupam SehgalTaysha Gene Therapies, Inc.; GlycoNetActive, not recruitingInfantile GM2 Gangliosidosis (Disorder)Canada
-
Innovo Therapeutics, Inc.Completed
-
Invenux, LLCState University of New York - Downstate Medical CenterActive, not recruitingSickle Cell Disease | Sickle-Beta Zero ThalassemiaUnited States
-
Ossium Health, Inc.Withdrawn
-
AmgenWithdrawnRelapsed/Refractory Multiple Myeloma
-
Adicet Bio, IncEnrolling by invitationLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell LymphomaUnited States
-
Abeona Therapeutics, IncTerminatedMucopolysaccharidosis III-BUnited States, Germany, France
-
Lumen Bioscience, Inc.CompletedC. Diff. InfectionsAustralia
-
Forte Biosciences, Inc.Terminated
-
PfizerCompletedReduction in Hypertrophic Skin ScarringUnited States
-
Neurocrine BiosciencesTakedaCompletedHealthy VolunteersUnited States
-
Stargazer Pharmaceuticals, Inc.Completed
-
AL-S PharmaUnknownAmyotrophic Lateral SclerosisCanada
-
Otonomy, Inc.Completed
-
United BioSource, LLCAveXis, Inc.Approved for marketing
-
ADC Therapeutics S.A.TerminatedAdvanced Solid TumorsUnited States
-
Benitec BioPharma LtdCompletedHead and Neck Squamous Cell CarcinomaAustralia, Russian Federation
-
Altor BioScienceCompletedHealthyUnited States
-
University of MinnesotaCompleted
-
Altor BioScienceNational Cancer Institute (NCI)CompletedAdvanced Solid TumorsUnited States
-
ViscofanMinisterio de Ciencia e Innovación, SpainUnknownHeart Failure With Reduced Ejection FractionSpain
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe DiseaseUnited States, United Kingdom, Germany, France, Italy, Portugal, Belgium, Netherlands
-
Curis, Inc.Terminated
-
Minerva NeurosciencesCompletedHealthy SubjectsIreland
-
LYSOGENECompletedMucopolysaccharidosis Type III A | Sanfilippo Disease Type AFrance
-
Orion Corporation, Orion PharmaEndo PharmaceuticalsCompletedProstate CancerUnited States, United Kingdom, Finland, France, Czech Republic, Estonia
-
AbbVie (prior sponsor, Abbott)CompletedAdvanced Solid TumorsUnited States, Australia
-
LYSOGENECompletedMucopolysaccharidosis Type III A | Sanfilippo Disease Type AFrance